Europe CRO Services MarketEurope CRO Services Market Future-proof Strategies: Trends, Competitor Dynamics, and Opportunities 2024-2032
Europe CRO Services Market by Service Type (Early Phase Development Services [Chemistry, Manufacturing, Controls (CMC), by Application (Oncology, Neurology, Cardiology, Infectious Disease, Metabolic Disorder, Renal/Nephrology, Others), by End-user (Pharmaceutical, Biotech Companies, Medical Device Companies, Academic, Research Institutes, Others), Forecast 2024-2032
Base Year: 2023
150 Pages
Europe CRO Services Market Future-proof Strategies: Trends, Competitor Dynamics, and Opportunities 2024-2032
Key Insights
The Europe CRO Services Market size was valued at USD 19.68 USD Billion in 2023 and is projected to reach USD 35.98 USD Billion by 2032, exhibiting a CAGR of 9.0 % during the forecast period. Contract research organizations (CROs) in Europe provide specialized services to the pharmaceutical industry such as clinical trial management, regulatory compliance, data management, and biostatistics for drugs, biotechnology, and medical devices. There are three major key types: the full-service CROs; the niche players; and the FSPs. Characteristics such as technology platforms, human resource capacity, and global access are emphasized. Usage varies from an active role in the creation and approval of the drug to a quick alert about side effects and adverse events. The current trends in the European market include the tendency towards outsourcing among companies, and the adoption of AI and machine learning for analyzing data while the growing global interest in the market of personalized medicine can be explained by its cost efficiency and the need for faster time-to-market.
Europe CRO Services Trends
- Growing R&D outsourcing by pharmaceutical and biotech companies
- Increasing prevalence of chronic diseases and rising healthcare expenditure
- Technological advancements in drug discovery and development processes
Driving Forces: What's Propelling the Europe CRO Services Market
- Outsourcing to Cut Costs: Pharmaceutical companies are turning to CROs to reduce operational costs associated with clinical trials.
- Access to Expertise and Infrastructure: CROs provide access to specialized expertise and infrastructure, which can be challenging for companies to maintain in-house.
- Regulatory Compliance: CROs help companies navigate complex regulatory requirements and ensure compliance with clinical trial guidelines.
Challenges and Restraints in the European CRO Services Market
- Data Security Concerns: Concerns about the secure handling of clinical trial data can hinder CRO adoption.
- Lack of Standardization: Lack of standardization in clinical trial practices across Europe can create challenges for CROs.
- Fierce Competition: The CRO market is highly competitive, with numerous players operating at different levels of service and cost.
Emerging Trends in Europe CRO Services
- Digitalization and Automation: CROs are leveraging technology to automate processes and improve efficiency.
- Patient-Centric Trials: CROs are increasingly focused on patient engagement and involvement in clinical trials.
- Personalized Medicine: CROs are supporting companies in the development of personalized medicine approaches based on patient characteristics.
Growth Catalysts in Europe CRO Services Industry
- Government Support: Governments are providing incentives and funding for clinical research and CRO services.
- Rise of Genomics and Big Data: Technological advancements in genomics and big data analytics are fueling research and development.
- Collaborative Partnerships: Collaborations between CROs, pharmaceutical companies, and research institutions are driving innovation and efficiency.
Market Segmentation: Europe CRO Services Analysis
Service Type:
- Early Phase Development Services
- Chemistry, Manufacturing, and Controls (CMC)
Application:
- Oncology
- Neurology
- Cardiology
- Infectious Disease
- Metabolic Disorder
- Renal/Nephrology
- Others
End-user:
- Pharmaceutical and Biotech Companies
- Medical Device Companies
- Academic and Research Institutes
- Others
Leading Players in the Europe CRO Services Market
- Pharmaceutical Product Development, LLC (Thermo Fisher Scientific) (U.S.)
- Medpace Holdings, Inc. (U.S.)
- Parexel International Corporation (Ireland)
- IQVIA (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- Charles River Laboratories (U.S.)
Significant developments in the Europe CRO Services Sector
- In 2022, IQVIA acquired Envigo, a leading provider of non-clinical CRO services in Europe, to expand its capabilities in the region.
- In 2021, Charles River Laboratories acquired Cognate BioServices, Inc., a leading provider of cell and gene therapy CRO services in Europe.
Comprehensive Coverage Europe CRO Services Market Report
This market report provides comprehensive coverage of the Europe Contract Research Organization (CRO) services market, including:
- Market size and trends
- Driving forces and challenges
- Emerging trends and growth catalysts
- Market segmentation
- Leading players and significant developments
- Regional Insight
- Pricing analysis
- Import and export analysis
- Segmentation based on service type, application, and end-user
- Patent/trademark analysis
Regional Insight
Europe is the largest CRO services market globally, with leading countries including Germany, the United Kingdom, France, and Switzerland.
Pricing Analysis
The report includes a comprehensive analysis of pricing trends in the Europe CRO services market, including:
- Historical pricing data
- Pricing factors
- Pricing strategies
Import And Export Analysis
The report provides a detailed analysis of international trade in CRO services in Europe, including:
- Export and import data
- Major trading partners
- Market access considerations
Segmentation
The report provides a detailed segmentation of the Europe CRO services market, including:
- Service type
- Application
- End-user
Patent/Trademark Analysis
The report includes a comprehensive analysis of patents and trademarks filed in the Europe CRO services market, including:
- Key patents and trademarks
- Patent landscaping
- Trademark protection
Europe CRO Services Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2018-2032 |
| Base Year | 2023 |
| Estimated Year | 2024 |
| Forecast Period | 2024-2032 |
| Historical Period | 2018-2023 |
| Growth Rate | CAGR of 9.0% from 2018-2032 |
| Segmentation |
|
Frequently Asked Questions
Table Of Content
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Growing Awareness Regarding Contraceptive Drugs Leads to Product Demand
- 3.3. Market Restrains
- 3.3.1. Lack of Skilled Professionals to Limit the Market Growth
- 3.4. Market Trends
- 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe CRO Services Market Analysis, Insights and Forecast, 2018-2030
- 5.1. Market Analysis, Insights and Forecast - by Service Type
- 5.1.1. Early Phase Development Services [Chemistry
- 5.1.2. Manufacturing
- 5.1.3. Controls (CMC
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Oncology
- 5.2.2. Neurology
- 5.2.3. Cardiology
- 5.2.4. Infectious Disease
- 5.2.5. Metabolic Disorder
- 5.2.6. Renal/Nephrology
- 5.2.7. Others
- 5.3. Market Analysis, Insights and Forecast - by End-user
- 5.3.1. Pharmaceutical
- 5.3.2. Biotech Companies
- 5.3.3. Medical Device Companies
- 5.3.4. Academic
- 5.3.5. Research Institutes
- 5.3.6. Others
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.1. Market Analysis, Insights and Forecast - by Service Type
- 6. Germany Europe CRO Services Market Analysis, Insights and Forecast, 2018-2030
- 6.1. Market Analysis, Insights and Forecast - By Service Type
- 6.1.1 Early Phase Development Services [Chemistry
- 6.1.2 Manufacturing and Controls (CMC
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1 Oncology
- 6.2.2 Neurology
- 6.2.3 Cardiology
- 6.2.4 Infectious Disease
- 6.2.5 Metabolic Disorder
- 6.2.6 Renal/Nephrology
- 6.2.7 and Others
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1 Pharmaceutical and Biotech Companies
- 6.3.2 Medical Device Companies
- 6.3.3 Academic and Research Institutes
- 6.3.4 and Others
- 7. United Kingdom Europe CRO Services Market Analysis, Insights and Forecast, 2018-2030
- 7.1. Market Analysis, Insights and Forecast - By Service Type
- 7.1.1 Early Phase Development Services [Chemistry
- 7.1.2 Manufacturing and Controls (CMC
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1 Oncology
- 7.2.2 Neurology
- 7.2.3 Cardiology
- 7.2.4 Infectious Disease
- 7.2.5 Metabolic Disorder
- 7.2.6 Renal/Nephrology
- 7.2.7 and Others
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1 Pharmaceutical and Biotech Companies
- 7.3.2 Medical Device Companies
- 7.3.3 Academic and Research Institutes
- 7.3.4 and Others
- 8. France Europe CRO Services Market Analysis, Insights and Forecast, 2018-2030
- 8.1. Market Analysis, Insights and Forecast - By Service Type
- 8.1.1 Early Phase Development Services [Chemistry
- 8.1.2 Manufacturing and Controls (CMC
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1 Oncology
- 8.2.2 Neurology
- 8.2.3 Cardiology
- 8.2.4 Infectious Disease
- 8.2.5 Metabolic Disorder
- 8.2.6 Renal/Nephrology
- 8.2.7 and Others
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1 Pharmaceutical and Biotech Companies
- 8.3.2 Medical Device Companies
- 8.3.3 Academic and Research Institutes
- 8.3.4 and Others
- 9. Italy Europe CRO Services Market Analysis, Insights and Forecast, 2018-2030
- 9.1. Market Analysis, Insights and Forecast - By Service Type
- 9.1.1 Early Phase Development Services [Chemistry
- 9.1.2 Manufacturing and Controls (CMC
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1 Oncology
- 9.2.2 Neurology
- 9.2.3 Cardiology
- 9.2.4 Infectious Disease
- 9.2.5 Metabolic Disorder
- 9.2.6 Renal/Nephrology
- 9.2.7 and Others
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1 Pharmaceutical and Biotech Companies
- 9.3.2 Medical Device Companies
- 9.3.3 Academic and Research Institutes
- 9.3.4 and Others
- 10. Spain Europe CRO Services Market Analysis, Insights and Forecast, 2018-2030
- 10.1. Market Analysis, Insights and Forecast - By Service Type
- 10.1.1 Early Phase Development Services [Chemistry
- 10.1.2 Manufacturing and Controls (CMC
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1 Oncology
- 10.2.2 Neurology
- 10.2.3 Cardiology
- 10.2.4 Infectious Disease
- 10.2.5 Metabolic Disorder
- 10.2.6 Renal/Nephrology
- 10.2.7 and Others
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1 Pharmaceutical and Biotech Companies
- 10.3.2 Medical Device Companies
- 10.3.3 Academic and Research Institutes
- 10.3.4 and Others
- 11. Rest of Europe Europe CRO Services Market Analysis, Insights and Forecast, 2018-2030
- 11.1. Market Analysis, Insights and Forecast - By Service Type
- 11.1.1 Early Phase Development Services [Chemistry
- 11.1.2 Manufacturing and Controls (CMC
- 11.2. Market Analysis, Insights and Forecast - By Application
- 11.2.1 Oncology
- 11.2.2 Neurology
- 11.2.3 Cardiology
- 11.2.4 Infectious Disease
- 11.2.5 Metabolic Disorder
- 11.2.6 Renal/Nephrology
- 11.2.7 and Others
- 11.3. Market Analysis, Insights and Forecast - By End-user
- 11.3.1 Pharmaceutical and Biotech Companies
- 11.3.2 Medical Device Companies
- 11.3.3 Academic and Research Institutes
- 11.3.4 and Others
- 12. Competitive Analysis
- 12.1. Market Share Analysis 2023
- 12.2. Company Profiles
- 12.2.1 Pharmaceutical Product Development LLC (Thermo Fisher Scientific ) (U.S.)
- 12.2.1.1. Overview
- 12.2.1.2. Products
- 12.2.1.3. SWOT Analysis
- 12.2.1.4. Recent Developments
- 12.2.1.5. Financials (Based on Availability)
- 12.2.2 Medpace Holdings Inc. (U.S.)
- 12.2.2.1. Overview
- 12.2.2.2. Products
- 12.2.2.3. SWOT Analysis
- 12.2.2.4. Recent Developments
- 12.2.2.5. Financials (Based on Availability)
- 12.2.3 Parexel International Corporation (Ireland)
- 12.2.3.1. Overview
- 12.2.3.2. Products
- 12.2.3.3. SWOT Analysis
- 12.2.3.4. Recent Developments
- 12.2.3.5. Financials (Based on Availability)
- 12.2.4 IQVIA (U.S.)
- 12.2.4.1. Overview
- 12.2.4.2. Products
- 12.2.4.3. SWOT Analysis
- 12.2.4.4. Recent Developments
- 12.2.4.5. Financials (Based on Availability)
- 12.2.5 Laboratory Corporation of America Holdings (U.S.)
- 12.2.5.1. Overview
- 12.2.5.2. Products
- 12.2.5.3. SWOT Analysis
- 12.2.5.4. Recent Developments
- 12.2.5.5. Financials (Based on Availability)
- 12.2.6 Charles River Laboratories (U.S.)
- 12.2.6.1. Overview
- 12.2.6.2. Products
- 12.2.6.3. SWOT Analysis
- 12.2.6.4. Recent Developments
- 12.2.6.5. Financials (Based on Availability)
- 12.2.7 PHASTAR (U.K.)
- 12.2.7.1. Overview
- 12.2.7.2. Products
- 12.2.7.3. SWOT Analysis
- 12.2.7.4. Recent Developments
- 12.2.7.5. Financials (Based on Availability)
- 12.2.8 Oy 4Pharma Ltd (Finland)
- 12.2.8.1. Overview
- 12.2.8.2. Products
- 12.2.8.3. SWOT Analysis
- 12.2.8.4. Recent Developments
- 12.2.8.5. Financials (Based on Availability)
- 12.2.9 PSI (Switzerland)
- 12.2.9.1. Overview
- 12.2.9.2. Products
- 12.2.9.3. SWOT Analysis
- 12.2.9.4. Recent Developments
- 12.2.9.5. Financials (Based on Availability)
- 12.2.10 Icon plc (Ireland)
- 12.2.10.1. Overview
- 12.2.10.2. Products
- 12.2.10.3. SWOT Analysis
- 12.2.10.4. Recent Developments
- 12.2.10.5. Financials (Based on Availability)
- 12.2.1 Pharmaceutical Product Development LLC (Thermo Fisher Scientific ) (U.S.)
List of Figures
- Figure 1: Europe CRO Services Market Revenue Breakdown (USD Billion, %) by Product 2023 & 2031
- Figure 2: Europe CRO Services Market Value Share (%), by Service Type 2023 & 2031
- Figure 3: Europe CRO Services Market Value Share (%), by Application 2023 & 2031
- Figure 4: Europe CRO Services Market Value Share (%), by End-user 2023 & 2031
- Figure 5: Europe CRO Services Market Share (%) by Company 2023
List of Tables
- Table 1: Europe CRO Services Market Revenue USD Billion Forecast, by Service Type 2018 & 2031
- Table 2: Europe CRO Services Market Revenue USD Billion Forecast, by Application 2018 & 2031
- Table 3: Europe CRO Services Market Revenue USD Billion Forecast, by End-user 2018 & 2031
- Table 4: Europe CRO Services Market Revenue USD Billion Forecast, by Region 2018 & 2031
- Table 5: Europe CRO Services Market Revenue USD Billion Forecast, by Service Type 2018 & 2031
- Table 6: Europe CRO Services Market Revenue USD Billion Forecast, by Application 2018 & 2031
- Table 7: Europe CRO Services Market Revenue USD Billion Forecast, by End-user 2018 & 2031
- Table 8: Europe CRO Services Market Revenue USD Billion Forecast, by Region 2018 & 2031
- Table 9: Europe CRO Services Market Revenue USD Billion Forecast, by Service Type 2018 & 2031
- Table 10: Europe CRO Services Market Revenue USD Billion Forecast, by Application 2018 & 2031
- Table 11: Europe CRO Services Market Revenue USD Billion Forecast, by End-user 2018 & 2031
- Table 12: Europe CRO Services Market Revenue USD Billion Forecast, by Country 2018 & 2031
- Table 13: Germany Europe CRO Services Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 14: United Kingdom Europe CRO Services Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 15: France Europe CRO Services Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 16: Italy Europe CRO Services Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 17: Spain Europe CRO Services Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 18: Rest of Europe Europe CRO Services Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
| Aspects | Details |
|---|---|
| Study Period | 2018-2032 |
| Base Year | 2023 |
| Estimated Year | 2024 |
| Forecast Period | 2024-2032 |
| Historical Period | 2018-2023 |
| Growth Rate | CAGR of 9.0% from 2018-2032 |
| Segmentation |
|
STEP 1 - Identification of Relevant Samples Size from Population Database
STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.
Note* : In applicable scenarios
STEP 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
STEP 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
About Market Research Forecast
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
